Clinical Trial

Assessing CSF Flow Dynamics in Pediatric Hemorrhagic Hydrocephalus

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the safety and efficacy of ventricular microdosing of indocyanine green (ICG) in order to assess cerebrospinal fluid (CSF) ventricular dynamics and extracranial CSF outflow using fluorescent Cap-based Transcranial Optical Tomography (fCTOT) and Near-InfraRed Fluorescent (NIRF) imaging and to evaluate inflammation markers of the CSF and to correlate with CSF ventricular dynamics, extracranial outflow into the lymphatics, ventriculomegaly, and patient's clinical outcome in order to understand how inflammation may impact that status of extracranial outflow.
Trial Details
NCT Number NCT06994949
Lead Sponsor Eva Sevick
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS)
Conditions Post-hemorrhagic Hydrocephalus (PHH)
Enrollment 20 participants
Start Date 2025-01-14
Primary Completion 2029-01-03 (estimated)
Study Completion 2029-01-03 (estimated)
Updated on ClinicalTrials.gov 2025-05-29